{{Rsnum
|rsid=1491850
|Chromosome=11
|position=27728178
|Orientation=plus
|GMAF=0.3921
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 15.0 | 54.9 | 30.1
| HCB | 21.2 | 48.9 | 29.9
| JPT | 17.7 | 41.6 | 40.7
| YRI | 5.4 | 33.3 | 61.2
| ASW | 7.1 | 46.4 | 46.4
| CHB | 21.2 | 48.9 | 29.9
| CHD | 23.9 | 49.5 | 26.6
| GIH | 13.9 | 39.6 | 46.5
| LWK | 7.3 | 33.6 | 59.1
| MEX | 15.5 | 50.0 | 34.5
| MKK | 8.3 | 34.6 | 57.1
| TSI | 18.6 | 47.1 | 34.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=21188787
|Title=Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder
}}

{{PMID Auto
|PMID=19589503
|Title=A brain-derived neurotrophic factor haplotype is associated with therapeutic response in obsessive-compulsive disorder.
}}

{{PMID Auto
|PMID=20004415
|Title=Serotonergic functioning as measured by the loudness dependence of auditory evoked potentials is related to a haplotype in the brain-derived neurotrophic factor (BDNF) gene.
}}

{{PMID Auto
|PMID=21172166
|Title=Pharmacogenetics of antidepressant response.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}